Polakis P .

Abrahamsson, Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. 2009, Pubmed

Abrahamsson, Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. 2009, Pubmed
Akiri, Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. 2009, Pubmed
Ashihara, beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model. 2009, Pubmed
Bafico, An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. 2004, Pubmed
Behrens, Functional interaction of beta-catenin with the transcription factor LEF-1. 1996, Pubmed , Xenbase
Björklund, The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. 2009, Pubmed
Brabletz, Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. 2001, Pubmed
Brunori, Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. 2001, Pubmed
Chapman, Improved survival with vemurafenib in melanoma with BRAF V600E mutation. 2011, Pubmed
Chen, Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. 2009, Pubmed
Chung, beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. 2004, Pubmed
Clements, Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. 2003, Pubmed
Conaway, Function and regulation of the Mediator complex. 2011, Pubmed
Cong, A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. 2003, Pubmed
Daniels, ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. 2002, Pubmed
Davidson, Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. 2005, Pubmed , Xenbase
DeAlmeida, The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. 2007, Pubmed
Deka, Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. 2010, Pubmed
Donner, CDK8 is a stimulus-specific positive coregulator of p53 target genes. 2007, Pubmed
Eguchi, ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription. 2005, Pubmed
Eklof Spink, Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. 2001, Pubmed
Firestein, CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. 2008, Pubmed
Fujii, An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. 2007, Pubmed
Gandhirajan, Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo. 2010, Pubmed
Geyer, β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. 2011, Pubmed
Gonsalves, An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. 2011, Pubmed
Gottardi, E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. 2001, Pubmed
Graham, The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT. 2002, Pubmed , Xenbase
Grandy, Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. 2009, Pubmed , Xenbase
Green, Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. 2001, Pubmed
Groden, Identification and characterization of the familial adenomatous polyposis coli gene. 1991, Pubmed
Hecht, The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. 2000, Pubmed , Xenbase
Hermiston, Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. 1995, Pubmed
Herschkowitz, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. 2007, Pubmed
Hinck, Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin. 1994, Pubmed
Howe, Wnt signaling and breast cancer. 2004, Pubmed
Huang, Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. 2009, Pubmed
Huber, Three-dimensional structure of the armadillo repeat region of beta-catenin. 1997, Pubmed
Huber, The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. 2001, Pubmed
Jamieson, Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. 2004, Pubmed
Jessen, Pygopus and the Wnt signaling pathway: a diverse set of connections. 2008, Pubmed
Khramtsov, Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. 2010, Pubmed
Kim, Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors. 2002, Pubmed
Kinzler, Identification of FAP locus genes from chromosome 5q21. 1991, Pubmed
Kuhnert, Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. 2004, Pubmed
Lammi, Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. 2004, Pubmed
Lee, RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. 2010, Pubmed
Lepourcelet, Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. 2004, Pubmed , Xenbase
Lin, Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. 2000, Pubmed
Liu, Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. 2002, Pubmed , Xenbase
Lukashev, Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. 2005, Pubmed
Major, Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. 2007, Pubmed , Xenbase
Malanchi, Cancer stem cells: never Wnt away from the niche. 2009, Pubmed
Malanchi, Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. 2008, Pubmed
Marvin, AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. 2011, Pubmed
Matsuda, WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. 2009, Pubmed
Minke, Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. 2009, Pubmed
Miyagishi, Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. 2000, Pubmed
Molenaar, XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. 1996, Pubmed , Xenbase
Mologni, Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2. 2010, Pubmed
Morin, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. 1997, Pubmed
Morin, Apoptosis and APC in colorectal tumorigenesis. 1996, Pubmed
Mosimann, Beta-catenin hits chromatin: regulation of Wnt target gene activation. 2009, Pubmed
Munemitsu, Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. 1995, Pubmed
Nguyen, WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. 2009, Pubmed
Nusse, Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. 1982, Pubmed
Peerlinck, Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. 2009, Pubmed
Pinto, Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. 2003, Pubmed
Polakis, The many ways of Wnt in cancer. 2007, Pubmed
Poulikakos, Mutant BRAF melanomas--dependence and resistance. 2011, Pubmed
Reya, Wnt signalling in stem cells and cancer. 2005, Pubmed
Roh, Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. 2001, Pubmed
Rubinfeld, Stabilization of beta-catenin by genetic defects in melanoma cell lines. 1997, Pubmed
Salahshor, The links between axin and carcinogenesis. 2005, Pubmed
Sampietro, Crystal structure of a beta-catenin/BCL9/Tcf4 complex. 2006, Pubmed , Xenbase
Satoh, AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. 2000, Pubmed
Scholer-Dahirel, Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. 2011, Pubmed
Sorlie, Repeated observation of breast tumor subtypes in independent gene expression data sets. 2003, Pubmed
Su, Association of the APC tumor suppressor protein with catenins. 1993, Pubmed
Takahashi-Yanaga, Targeting Wnt signaling: can we safely eradicate cancer stem cells? 2010, Pubmed
Tetsu, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. 1999, Pubmed
Thorne, Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. 2010, Pubmed , Xenbase
Tian, A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. 2011, Pubmed
van de Wetering, The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. 2002, Pubmed
Verma, Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. 2003, Pubmed
von Kries, Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. 2000, Pubmed
Waaler, Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. 2011, Pubmed , Xenbase
Wang, CK2 controls the recruitment of Wnt regulators to target genes in vivo. 2006, Pubmed
Wang, The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. 2010, Pubmed
Wei, Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. 2010, Pubmed
Willert, Wnt signaling: is the party in the nucleus? 2006, Pubmed
Xing, Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. 2003, Pubmed , Xenbase
Xu, Mechanistic insights from structural studies of beta-catenin and its binding partners. 2007, Pubmed
Yan, The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. 2012, Pubmed
Yang, FZD7 has a critical role in cell proliferation in triple negative breast cancer. 2011, Pubmed
Yeung, β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. 2010, Pubmed
Zeng, siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. 2007, Pubmed
Zhang, Inhibition of Wnt signaling by Dishevelled PDZ peptides. 2009, Pubmed
Zhao, Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. 2007, Pubmed